PTIX - Protagenic Therapeutics, Inc.\new
0.74
-0.560 -75.676%
Share volume: 1,922,073
Last Updated: 01-02-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.20%
PREVIOUS CLOSE
CHG
CHG%
$1.30
-0.56
-0.43%
Summary score
52%
Profitability
35%
Dept financing
46%
Liquidity
38%
Performance
75%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 30-Jun-2022 - 30-Jun-2026
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-44.29%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
47.26%
Debt ratio change over timeo
0%
Current Ratio
4.9%
Quick Ratio
0.29%
Cash Position Ratio
0.77%
Short-term ratios 30-Jun-2025 - 30-Jun-2026
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-18.07%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
193.96%
Debt ratio change over timeo
0%
Current Ratio
0.29%
Quick Ratio
0.29%
Cash Position Ratio
0.28%
Last quarter ratios 30-Jun-2026
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-18.07%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
193.96%
Debt ratio change over time
0%
Current Ratio
0.29%
Quick Ratio
0.29%
Cash Position Ratio
0.28%
Performance ratios (change over 4 years) 30-Jun-2022 - 30-Jun-2026
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | PTIX | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 0% | 10.46% | 12.32% | 0% |
| Return on assets | -44.29% | 4.77% | 3.14% | 1.47% |
| Return on sales | 0% | 31.13% | 25.09% | 22.8% |
| Return on invested capital | 0% | 7.53% | 12.95% | 0% |
| Profitability | 0% | 86% | 87% | 26% |
| Total debt ratio | 47.26% | 80.29% | 59.63% | 95.26% |
| Debt ratio change over time | 0% | -31.24% | -122.96% | 0% |
| Dept financing | 37% | 21% | 16% | 25% |
| Current Ratio | 0.29% | 1.56% | 1.05% | 0.7% |
| Quick Ratio | 0.29% | 1.22% | 0.78% | 0.58% |
| Cash Position Ratio | 0.28% | 0.23% | 0.36% | 0.13% |
| Liquididy | 58% | 36% | 44% | 30% |
| Short-term ratios | PTIX | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | -18.07% | 6.82% | 3.19% | 1.76% |
| Return on sales | 0% | 42.63% | 25.7% | 19.71% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 50% | 50% | 27% | 18% |
| Total debt ratio | 193.96% | 77.86% | 58.98% | 102.21% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 50% | 10% | 8% | 13% |
| Current Ratio | 0.29% | 1.56% | 1.05% | 0.7% |
| Quick Ratio | 0.29% | 1.22% | 0.78% | 0.58% |
| Cash Position Ratio | 0.28% | 0.23% | 0.36% | 0.13% |
| Liquididy | 30% | 66% | 58% | 32% |